Implementation of a COVID-19 Genomic Surveillance Regional Network for Latin America and Caribbean region.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
10
2020
accepted:
27
01
2022
entrez:
3
3
2022
pubmed:
4
3
2022
medline:
11
3
2022
Statut:
epublish
Résumé
The timely release of SARS-CoV-2 first genomic sequences allowed the identification of the etiologic agent and development of diagnostic protocols. Genomic sequencing was a crucial step in generating data for driving laboratory response and detections of SARS-CoV-2 since the start of the COVID-19 pandemic. Because of all the progression and achievements that timely release of genetic sequence data represents in the public health response, the Pan American Health Organization (PAHO) in collaboration with countries' public health laboratories, started implementation of a network for strengthening the Latin America and Caribbean (LAC) region on timely generation of SARS-CoV-2 genomic data. Here we describe the implementation of the COVID-19 Genomic Surveillance Regional Network in the Americas region during the beginning of the pandemic. The establishment of this network has strengthened laboratory response capacity at the country level, as well as facilitated timely release of SARS-CoV-2 genomic information to be used to complement the multiple response strategies for COVID-19 pandemic mitigation. As genomic epidemiology is useful for guiding public health decisions on outbreak and response, we also analysed the first SARS-CoV-2 genomic sequence data from countries of the Latin America and Caribbean Region.
Identifiants
pubmed: 35239677
doi: 10.1371/journal.pone.0252526
pii: PONE-D-20-31739
pmc: PMC8893691
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0252526Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Front Public Health. 2020 Sep 22;8:562615
pubmed: 33072699
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Acta Pharmacol Sin. 2020 Sep;41(9):1141-1149
pubmed: 32747721
Rev Med Virol. 2002 Nov-Dec;12(6):375-89
pubmed: 12410529
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Antiviral Res. 2019 Jul;167:45-67
pubmed: 30974127
PLoS One. 2020 Mar 10;15(3):e0227962
pubmed: 32155152
PLoS One. 2021 Jun 29;16(6):e0253334
pubmed: 34185777
Cell. 2020 Aug 20;182(4):794-795
pubmed: 32697970
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Vaccine. 2008 Sep 12;26 Suppl 4:D31-4
pubmed: 19230156
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Nat Microbiol. 2020 Apr;5(4):536-544
pubmed: 32123347
Rev Assoc Med Bras (1992). 2020 Sep 21;66Suppl 2(Suppl 2):41-47
pubmed: 32965355
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
J Int AIDS Soc. 2020 Aug;23(8):e25587
pubmed: 32767707
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638